Report cover image

ClearNote Health - Product Pipeline Analysis, 2026 Update

Publisher GlobalData
Published Apr 20, 2026
Length 36 Pages
SKU # GBDT21121748

Description

Summary

ClearNote Health (ClearNote) is a cancer detection company. The company utilizes a standard blood draw which is a proprietary epigenomic platform that combines biology and artificial intelligence to provide a more comprehensive view of biology to identify DNA-based changes in biology as cancer develops. It also offers biopharma services. The company provides tests for pancreatic cancer and ovarian cancer. It serves clinicians and patients. The company operates offices in San Diego and San Mateo, the US. ClearNote is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company ClearNote Health
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company

Table of Contents

36 Pages
ClearNote Health Company Overview
ClearNote Health Company Snapshot
ClearNote Health Pipeline Products and Ongoing Clinical Trials Overview
ClearNote Health – Pipeline Analysis Overview
ClearNote Health - Key Facts
ClearNote Health - Major Products and Services
ClearNote Health Pipeline Products by Development Stage
ClearNote Health Ongoing Clinical Trials by Trial Status
ClearNote Health Pipeline Products Overview
Avantect Multi-Cancer Detection Test
Avantect Multi-Cancer Detection Test Product Overview
Avantect Multi-Cancer Detection Test Clinical Trial
ClearNote Health Pancreatic Cancer Detection Test
ClearNote Health Pancreatic Cancer Detection Test Product Overview
Non-Small Cell Lung Cancer Detection Test
Non-Small Cell Lung Cancer Detection Test Product Overview
ClearNote Health - Key Competitors
ClearNote Health - Key Employees
ClearNote Health - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
ClearNote Health, Recent Developments
Mar 31, 2026: BCAL Submits MSAC Application for Avantect Pancreatic Cancer Early Detection Blood Test
Mar 26, 2026: BCAL Accelerates National Commercial Rollout of Avantect Pancreatic and Ovarian Early Detection Blood Tests
Feb 23, 2026: Clearnote Health’s Enhanced Avantect Pancreatic Cancer Test Delivers Industry-Leading Early Detection Performance
Dec 09, 2025: BCAL to enable pancreatic and ovarian cancer early detection blood testing across Australia starting in January
Sep 25, 2025: ClearNote Health Secures UKCA Approval for Avantect Multi-Cancer Detection and Ovarian Cancer Tests
Sep 25, 2025: Clearnote Health Receives in Vitro Diagnostic Approval in United Kingdom for Avantect Multi-Cancer Detection Test and Avantect Ovarian Cancer Test
Jul 09, 2025: Clearnote Health Receives First in Vitro Diagnostic Approval for Its Avantect Pancreatic Cancer Test
Jun 17, 2025: ClearNote Health initiates study of test to detect early pancreatic cancer
May 06, 2025: Human Longevity Expands Cancer Prevention Offering by Selecting the ClearNote Health Avantect Early Detection Pancreatic Cancer Test
Apr 23, 2025: ClearNote Health to Showcase Latest Advancements in Tumor Subtyping and Circulating Tumor Fraction Technologies at AACR Annual Meeting 2025
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
ClearNote Health Pipeline Products and Ongoing Clinical Trials Overview
ClearNote Health Pipeline Products by Equipment Type
ClearNote Health Pipeline Products by Indication
ClearNote Health Ongoing Clinical Trials by Trial Status
ClearNote Health, Key Facts
ClearNote Health, Major Products and Services
ClearNote Health Number of Pipeline Products by Development Stage
ClearNote Health Pipeline Products Summary by Development Stage
ClearNote Health Ongoing Clinical Trials by Trial Status
ClearNote Health Ongoing Clinical Trials Summary
Avantect Multi-Cancer Detection Test - Product Status
Avantect Multi-Cancer Detection Test - Product Description
Avantect Multi-Cancer Detection Test - Burn Pit Exposure in Veterans: A Cancer Screening Pilot Study at the Inova Saville Cancer Screening & Prevention Center
Avantect Multi-Cancer Detection Test - The Vanguard Study: Testing a New Way to Screen for Cancer
ClearNote Health Pancreatic Cancer Detection Test - Product Status
ClearNote Health Pancreatic Cancer Detection Test - Product Description
Non-Small Cell Lung Cancer Detection Test - Product Status
Non-Small Cell Lung Cancer Detection Test - Product Description
ClearNote Health, Key Employees
ClearNote Health, Other Locations
Glossary
List of Figures
ClearNote Health Pipeline Products by Equipment Type
ClearNote Health Pipeline Products by Development Stage
ClearNote Health Ongoing Clinical Trials by Trial Status

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us